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compared with the static control. We realized that the
ANDV A test was too stringent for the detection of
significant changes in gene expression in the face of
biological variations among experiments. In the ab-
sence of a better way to analyze the results of all three
time periods, we chose to work on the comparison of
only one pair of data (24 h shear vs. static control) by
the use of the paired Student's t-test (6). At the sug-
gestion of one of us (D. M. Rocke), we used the method
of longitudinal analysis for statistical analysis (9) as a
starting point to develop an improved significance test.
This new test provides a more sensitive way to analyze
DNA micro array data obtained from sets of data from
different experiments with several time points. In the
present paper, this new significance test has been
applied to the entire data set obtained from three
different experiments, each with three time points,
including the 24-h results we previously reported (6).
The results indicate that this new significance test can
detect three times as many genes as the ANaV A test at
the same cutoff point of P value. Many of the additional
genes detected by this new method are in agreement
with the known temporal changes that have been re-
ported. Since most biological studies involve experi-
ments with several time points and considerable indi-
vidual variations, this new significant test should have
significant application to the study of temporal modu-
lation of gene expression in response to experimental
manipulation. The same test can also be applied to the
comparison of results obtained on different organ/tis-
sues or to experiments with different degrees of treat-
ment for assessing the dose-response relationship in
gene expression. Therefore, this new significance test
may have broad application for the analysis of gene-
expression studies and, in fact, to other biological stud-
ies in general.
Zhao, Yihua, Benjamin P. C. Chen, Hui Miao, Suli
Yuan, Yi-Shuan Li, Yingli Bu, David M. Rocke, and Shu
Chien. Improved significance test for DNA microarray data:
temporal effects of shear stress on endothelial genes. Physiol
Genomics 12: 1-11, 2002. First published October 22, 2002;
10.1152/physiolgenomics.OOO24.2002.-Statistical methods for
identifying differentially expressed genes from microarray data
are evolving. We developed a test for the statistical significance
of differential expression as a function of time. When applied to
microarray data obtained from endothelial cells exposed to
shearing for different durations, the new multi-group test (G-
test) identified three times as many genes as the one-way
ANOVA at the same significance level. Using simulated data,
we showed that this increase in sensitivity was achieved with-
out sacrificing specificity. Several genes known to respond to
shear stress by Northern blotting were identified by the G-test
at P :5; 0.01 (but not by ANOV A), with similar temporal pat-
terns. The validity and utility of the G-test were further sup-
ported by the examination of a few more example genes in
relation to the present knowledge of their regulatory mecha-
nisms. This new significance test may have broad application
for the analysis of gene-expression studies and, in fact, to other
biological studies in general.
biological variability; microarray data analysis; differential
gene expression; longitudinal analysis; statistical test
THE DNA MICROARRAY TECHNOLOGY develop,ed in recent
years provides a powerful and efficient tool to rapidly
compare the differential expression of a large number
of genes (8, 10, 12, 23, 26, 29), and the statistical
methods for identifying differentially expressed genes
from microarray data are still evolving (18, 21, 22, 24,
25). Using the DNA microarray approach, we investi-
gated gene expression profiles in cultured human aor-
tic endothelial cells (HAECs) in response to a laminar
shear stress at 12 dyn/cm2. We performed the experi-
ments at 1, 4, and 24 h after shearing, :1S well as on
static controls. When the ANOV A test was applied to
analyze the results, a very small number of genes were
found to have significant changes after shearing, when
-_0
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ANALYTICAL METHODS
Rationale. In a DNA microarray study, the observed
variations in the expression levels of a given gene can
be attributed to the following: A) the effects of the
treatments, B) the biological variability among the
subjects tested, and C) the experimentaVmeasurement
errors. The focus of this work is on testing the statis-
tical significance of the effects of a treatment on gene
2 the American Physiological Society 1
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expression (A), in which both Band C are regarded as
noise. We postulate that each genome is BL redundant
network that provides flexibility in the rl~gulation of
the gene expression, thus contributing to the variabil-
ity among gene expression profiles obtained from indi-
vidual experiments. Consequently, the bio:logical vari-
ability B could be greater than the experimental errors
C. Therefore, the power of statistical te:sts for the
significance of treatment effects (A) can be greatly
improved if B can be isolated. The achievement of this
goal requires an appropriate experimental design. Re-
peats of the same experiment on different subjects
produce a group of data sets, in which 1;he subject-
subject variation (i.e., B) can be identified. In the ex-
periments reported here, each data set comprises data
collected from experiments on the same batch of cul-
tured cells subject to shearing of different time dura-
tions or kept as static control, as described below. In
this case, a subject means a cell batch.
The subject-subject variation (B) may have two com-
ponents: the variation among subjects in the baseline
of a gene's expression and that in the responsiveness of
the gene to the treatment. Correspondinl~ly, we can
isolate, at least partially, the effects of B by subtracting
from each data set, gene by gene, the gene-specific
means and then dividing the results by the gene-spe-
cific standard deviations, as described in the section
below on Statistical tests.
Global normalization. Let Xijk denote the intensity
measured (readout) for gene i, with treatment j, from
subject k, where i = 1, 2,. .., I;j = 1,2,. .., J; and k =
1, 2,. .., K. For the experiments analyzed here (see
EXPERIMENTAL MATERIALS AND METHODS), 1= 1,185 (no. of
genes), J = 4 (static control plus three time points after
shearing), and K = 3 (no. of experiments). Let X*jk
denote the data vector obtained from a sin~~le microar-
ray which corresponds to treatment j and subject k,
with its ith component being Xijk. Let Xi*k and xij*
denote, in a similar way, the corresponding data vec-
tors. Similarly, Xi** denotes the data matri:{ for gene i,
with rows for treatments and columns fC)r subjects.
Also used is the conventional dot notation, in which a
dot replacing an index indicates an average over the
whole range of the index. For example, X.jk denotes the
mean of the I components of X*jk, and Xi" ,denotes the
mean of the JK components of Xi**. Summation will be
explicitly stated, and repeated indices do ruJt automat-
ically indicate a summation.
The measured intensity Xijk has an arbitrary scale.
To compare the intensity readings for a gene between
different microarrays, we performed an array-wide
global normalization, i.e., dividing each XijA: by X'jk. All
intensities considered below are globally Jtlormalized,
and hereafter the notations Xijk, XiJ'" etc., always refer
to the globally normalized intensities.
Statistical model. We state explicitly the statistical
model here to provide clarity for the construction of a
test statistic and its null distribution. As :reasoned in
Rationale (above), in the absence of experimental er-
rors, the variability in measured intensities can be
explained by Xijk = aiJ'Yik + ~ik, with a constraint ai. =
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0, where aij is due to the treatment effects A, and ~ik
and 'Yik are, respectively, the baseline expression and
the responsiveness of gene i in subject k. If preferred,
one can set the standard deviation of aij to 1 to specify
the scale of 'Yik. With the inclusion of experimental
errors, we have
xii' = aij'Yik + ~i' + eij' (1)
In Eq. 1, aij is a fixed effect because it only applies to
the specified gene and treatment, whereas ~ik and 'Yik
are random effects because the K subjects are a
sample representing a larger population. The exper-
imental errors are assumed to be independently dis-
tributed as
eijk -N(O,<T~) (2)
No assumption is needed about the distributions of ~ik
and 'Yik for the statistical test described below.
In a standard approach of longitudinal analysis, it
would be assumed that subjects differ only in their
baseline levels, equivalent to setting 'Yik = 1 in Eq. 1.
In that case, Eq. 1 is reduced to a model of two-way
ANOV A. We introduce the multiplicative factor 'Yik to
account for the fact that subjects may also differ in
their responsiveness to a treatment, as reasoned in
Rationale (above). Indeed, experimental data show
that the responsiveness of many genes vary sig-
nificantly from subject to subject, as exemplified
by RGS3 ("regulator of G protein signaling 3") in
Fig. 2B.
Statistical tests. The null hypothesis to be tested is
ail = ai2 =. ..= aiJ = O. Statistical tests are performed
for each individual gene. Given data Xijk, compute
Yijk = (Xijk -Xi.k) ! 1 LJ (xu. -Xi.k)2/(J -1) (3)
~ "" j=l I.~u' -~i.kJ 'I." -.LJ
Note that in the absence of experimental error
Yij' = Yij. = aij! 1 L~ aV(J -1)
~ "" j=l Ui/I." -.LJ
Now, for each gene i, construct an ANOVAtable for the
derived data matrix Yi**
Source of Variation Sum of Squares Degree of Freedom
J
Between BTSS = K LCYu. -Yi..)2
treatments j -1 J -2
Residual RSS = TSS -BTSS (J -l)(K -1)
J K
TSS = LLCYulo -Yi..)2
Total jc11o=1 (J-1)K-1
where the degrees of freedom have been adjusted be-
cause of the data transformation via Eq. 3. The Yijk is
constructed in a way so that BTSS is a measure for the
treatment effects and RSS for the experimental errors.
We define a G statistic analogous to Fisher's F statistic.www.physiolgenomics.org
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BTSS/(J -2)G= -~
RSS/[(J -l)(K -1)]
This likelihood ratio is called G instead of ,(1' to empha
size that the null distribution of this G statistic is not
an F -distribution.
Under the null hypothesis (Xij = O. Eq. 1 reduces to
Xijk = J3ik + eijk (5)
For the error distribution given III Eq. ~~, It can be
shown that Yijk computed from the Xijk given by Eq. 5 is
equivalent in distribution to Yijk computed from Xijk -
N(O,l), independent of the distributions of J3ik and 'Yik
This allows us to readily compute the null distribution
of the G statistic by computer simulation (see Simu
lated data sets, below). The upper tail of 1~he G's null
distribution gives the P value, which is the probability
of having a G score randomly drawn from the null
distribution greater than the experimental. value ofG.
We will call this G-statistic-based test as G-test. and
denote the P value it yields as Pa
For comparison, we also computed P value for gene z
by directly applying the conventional one-~'ay ANOV A
to the data matrix Xi**, which will be denoted as P anova
Simulated data sets. A random number j~enerator is
used to assign Xijk -N(O, 1). Then, the Yijk values
defined in Eq. 3 are calculated from the sirtlulated Xijk,
and a G statistic is computed for each i a,s described
above. We computed 100,000 G statistics in this way to
generate a null distribution for the G statistic.
To compare the sensitivities and specific::ities of dif-
ferent statistical tests, simulated data se1;s with pre-
scribed expression patterns were generated based on
Eq. 1, with errors and random effects being assigned by
a random number generator.
To test the effects of subject-subject vanation, SImu-
lated data sets were generated from the eJcperimental
data by permuting the identities of subjects. Let Xijk
and Xijk be the experimental and simulated data, re-
spectively. A simulated group of data se1;s was con-
structed by letting each vector Xtj* be a random permu-
tation of vector XiJ"*' with the random permutation for
different (i, j) performed independently. One hundred
groups of subject-identity-permuted data sets gener-
ated from the same experimental group of data sets
were used.
~ (4)
1-
,~~ ~",;
.
EXPERIMENTAL MATERIALS AND METHOD~~
Experimental design. Of particular import;ance to the
present study is the experimental design. Three independent
sets of experiments were performed. In each set, HAECs
were subjected to a shear stress at 12 dyn/cm2 for 1, 4, and
24 h together with a paired control experim.~nt with the
HAECs kept under static condition. All cells \\'ere first cul-
tured to passage 3 (Cell culture, below) and k'ept frozen in
liquid nitrogen. Then, for each set of experiments, the cells
were thawed and further cultured for two morl~ passages to
obtain sufficient cells so that all the experiments within the
same set used the same batch of HAECs at passage 5.
However, three different batches of cells were used in the
three sets of experiments.
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Atlas Human Cancer 1.2 arrays (Clontech) were used in
these experiments. Each Atlas 1.2 array consists of four
separate filters. The four filters from the same set were used
to perform a set of experiments, one for each of the four
experiments. A total of three sets of filters were used, thus
providing three sets of experiments.
Cell culture and shear stress experiments. The experimen-
tal materials and methods were previously reported in detail
(6). Briefly, HAECs were obtained from Clonetics (San Diego,
CA) and cultured in endothelial cell growth medium-2
(EGM-2) supplemented with 2% fetal bovine serum (FBS),
hydrocortisone, hFGF-f3, VEGF, R3-IGF-I, ascorbic acid,
hEGF, GA-I000, and heparin (Clonetics). Cell cultures were
maintained in a humidified 95% air-5% CO2 incubator at
37°C. To impose shear stress on cultured cells, a glass slide
seeded with a confluent monolayer ofHAECs was mounted to
a parallel-plate flow chamber and connected to a flow system
as described by Frangos et al. (11). A laminar shear stress of
12 dyn/cm2 was generated by the flow resulting from a
hydrostatic pressure difference between two reservoirs. This
level of shear stress is encountered under physiological con-
ditions in the straight part of the aorta and frequently used
to study the effects of shear stress on endothelial cells. To
maintain the same cell environment, the flow experiments
were performed by using the same culture medium as in the
static culture, thus controlling the possible effects of growth
factors on gene expression. The whole flow system was kept
at 37°C and ventilated with 95% humidified air and 5% CO2.
Microarray experiments and imaging. For microarray ex-
periments, the total RNA was isolated by using STAT60 total
RNA purification reagent (Tel-Test "B"). The cells were lysed
in phenol-containing STAT60 solution and centrifuged. The
RNA-containing aqueous phase was isolated, and 0.6 vol of
isopropanol was added to precipitate RNA. The 20-30 ~g of
total RNA was subjected to reverse transcription (RT) reac-
tion and [33PJdCTP labeling using an Atlas Pure Total RNA
Labeling System (Clontech) and [33PJdCTP. The 33P-labeled
cDNA was hybridized to Atlas Human Cancer 1.2 arrays at
68°C for 16 h, followed by washing once in 2X SSC/1 % SDS at
68°C for 30 min and three times in O.IX SSC 0.5/%SDS at
68°C for 30 min. The hybridized array was then exposed to
Phospho Storage Screen (Molecular Dynamics), and the im-
ages were analyzed and quantified by using an Atlas Image
1.01 software (Clontech) to quantify the intensity of each of
the 1,185 spots.
RESULTS
Validation of the global normalization. The validity
of the global normalization is confirmed by the results
for GAPDH. The mRNA level of GAPDH in endothelial
cells is known to be not changed by shear (14) and has
been widely used as the negative control in studying
the regulation of gene expression in endothelial cells by
shear stress (4, 14, 15, 23). In this work, the normal-
ized intensity for GAPDH (P G = 0.78, P anova = 0.98) is
essentially constant across all the time points tested,
as shown in Fig. 1.
The high sensitivity of the a-test. When applied to the
experimental data, the a-test was found to be three
times more sensitive than ANOV A, as shown in Table
1. For example, at P :5 0.01, 61 genes were called
significant by a-test, whereas ANOV A called only 18
genes significant. The 61 genes that showed PG :5 0.01
are listed in Table 2. The results for all the 1,185 genes
are available as an online data supplement at http://
.www.physiolgenomics.org
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GAPDH: Pa = 0.78, P anova = 0.9!~
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Fig. 1. The gene expression level ofGAPDH, a negati.'Ve control, was
not changed by shear stress. Bars represent the globa.lly normalized
intensities for GAPDH from three independent; experiments
(means ::t: SE). Pa is the P value yielded by the G-statistic-based test.
PanDya is the P value computed directly applying the conventional
one-way ANaYA to the data matrix.
wibe.ucsd.edu/resources/microarray.sI1Ltml, which
are also published at the Physiological Genomics web
site.!
To examine how the G-test improves the sensitivity
of the statistical testing, we used simulated data with
prescribed patterns of gene expression. Data sets for
"positive" and "negative" genes were gene:rated in ac-
cordance of Eq. 1. For positive genes, effects <Xi" = (3/2,
-1/2, -1/2, -1/2), l3ik ~ N(1,<1~), 'Yik = 1, and error
distribution eijk ~ N(O, 1); 'Yik was set to 1 foJr simplicity.
Negative genes were generated in the sarne way, ex-
cept that effects <Xi" = (0, 0, 0, 0). For each group of
simulated data set, the index ranges were set to I =
100,000 to have a large sample size and J =: 4, K = 3 to
mimic the design of the experiments. Note that the
standard deviation of the experimental error was set to
unity and served as the measurement umit for the
effects <Xij and l3ik. The prescribed <Xi" for 1;he positive
genes is such that the hypothesized gene responds only
to one of the treatments (which one is imrnaterial) by
increasing its expression level by an amouLnt equal to
two standard deviations of the experimenta.l error. The
subject-subject variation was modulated in the simu-
lation by using different values of <113. The G-test and
ANOV A were applied to the simulated data, and the
sensitivity and specificity of a test at each fixed cutoff
point of P were computed as the fractions! of, respec-
tively, positive and negative genes correct:ly classified
by the test. The receiver operating characteristic
(ROC) curves of both tests were plotted in Fig. 2A for
various values of <113. ROC curves are commonly used
for comparing competing tests (1). In Fig. 2A, <113 = 0
through 4 were used to examine the effect!; of subject-
subject variation on the performance of the tests. It is
interesting to note that, in the absence of the subject-
ANOVA a-test + Permutation*p a-test
$0.01
$0.02
$0.05
$0.1
IThe Data Supplement (results for all the 1,185 I~enes) for this *Obtained by applying a-test to subject-identity-permuted exper-
article is available online at http://physiolgenomics.physiology. imental data (see ANALYTICAL METHODS). Numbers shown are the
orwc~content/fn1l/12/1/1/DCl. average of 100 computations.
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subject variation ({f~ = 0), ANOVA is actually more
(though only slightly) sensitive than the a-test. How-
ever, as the subject-subject variation increases, the
sensitivity of ANOV A (see the dashed lines) drops
rapidly; at (f~ = 3 [which is greater than the magnitude
of the treatment effect on positive genes, namely, 3/2 -
(-1/2) = 2], the sensitivity of ANOV A becomes too low
to distinguish the populations of positive and negative
genes, as indicated by the closeness of the dashed line
for {f~ = 3 to the diagonal dot line. In contrast, as
expected, the sensitivity of a-test is essentially not
affected by the subject-subject variation, as the ROC
curves produced by a-test with different values of {f~
are practically indistinguishable (the solid line in Fig.
2A). In summary, for data with sizable subject-subject
variations, the a-test is more sensitive than ANOV A at
the same level of specificity.
An example will help to illustrate the above obser-
vations. Figure 2B shows the actual experimental data
for gene RGS3. It is evident that both the baseline
expression and the responsiveness to shear stress of
the gene varied markedly among the three repeated
sets of experiments, each using a different batch of
cells. These observed variations are likely to be biolog-
ical in origin rather than experimental errors, for the
time course of regulation by shear was very similar in
the three sets of experiments, as shown in Fig. 2C,
which plots the same data transformed by Eq. 3. How-
ever, it should be noted that, if care is not taken to
minimize systematic experimental errors, then a non-
randomly distributed analytical variation could pro-
duce a similar pattern. For example, applying labeled
probes with different specific activities or quantities to
an array could produce changes in the observed base-
line (due to background) or responsiveness (due to
saturation), respectively. Without isolating the large
biological and nonrandomly distributed analytical
variations between subjects (cell batches), ANOV A
failed to detect the consistent pattern which shows the
effect of shear and yielded a P = 0.18. In contrast, the
a-test yielded a P < 0.01, indicating that the effect of
shear is statistically significant. The upregulation of
RGS3 by 1-h shear was confirmed by a Northern anal-
ysis (data not shown).
The other side of the coin of what is shown in Fig. 2A
is that ifmany more genes are found to be significant in
the same sets of data by the a-test than ANOV A, then
the biological variations between subjects are not small
compared with the effect of the treatment, i.e., shear-
Table 1. Number of genes showing statistical
significance at the indicated levels
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Table 2. Genes whose expression was signi:ficantly (Po .s 0.01) regulated by shear
Shear/Static
1.20:
1.73 :
0.95:
0.75 :
0.60:
1.01:
1.05:!
1.02 :!
1.09 :!
0.85:!
1.03 :!
1.29:!
1.47:!
1.81 :!
1.22:!
0.80:
1.19:!
0.91:!
1.33:!
0.89:!
1.70:!
0.79:!
0.78:!
O,90:!
1.31:!
1.02:!
0.43:!
1.04:!
0.56:!
1.10:!
1.31:!
0.41:!
1.21:!
0.88:!
2.13:!
1.92:!
0.61:!
1.02:!
1.33:!
0.63:!
0.80:!
0.95:!
0.82:!
0.98:!
0.82:!
0.88:!
0.74:!
1.34:!
1.12:!
0.77:!
1.46:!
0.85:!
1.42:!
1.10:!
1.32j
0.85j
1.17j
1.14j
0.98j
1.45j
2.10j
2.77 :t 0.35
0.71 :t 0.03
1.90 :t 0.01
0.78:t 0.05
1.19:t0.08
1.46:t 0.15
0.53:t 0.11
0.61 :t 0.05
1.53:t0.18
0.42:t 0.04
1.74:t0.15
0.78:t 0.14
0.49:t 0.14
1.37 :t 0.02
0.61:t 0.11
0.59:t0.18
1.04:t0.13
1.15:t 0.05
0.56:t 0.12
0.83 :t 0.08
1.70:t 0.20
0.48 :t 0.08
0.54 :t 0.06
1.91:t 0.10
1.76:t 0.26
0.76 z 0.10
0.36z0.14
1.30:t0.11
1.14:t 0.01
1.81z0.37
0.81z0.17
0.92z0.12
1.59z0.12
1.32 z 0.24
1.16 z 0.22
1.15 z 0.09
0.54 z 0.07
0.73 zO.06
2.18:t0.34
0.67 zO.10
0.60 z 0.07
1.98z0.31
0.76z0.03
1.32z0.12
0.54z0.12
1.78z0.18
0.40 z 0.02
0.80 z 0.06
0.51 z 0.20
0.82 zO.ll
0.73z0.18
0.58z0.13
1.54 z 0.08
1.48 :t 0.10
2.40z0.66
0.67 z 0.02
0.71z0.12
0.64 z 0.06
0.79z0.03
2.14:t 0.41
0.77z0.26
<0.01
<0.01
<0.01
<0.01
<0.01
<0.01
<0.01
<0.01
<0.01
<0.01
<0.01
<0.01
<0.01
<0.01
<0.01
<0.01
<0.01
<0.01
<0.01
<0.01
<0.01
<0.01
<0.01
<0.01
<0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
Matrix metalloproteinase 1 (MMPl)
Regulator of G protein signaling 3 (RGS3)
Tie-2, tyrosine-protein kinase receptor
Zinc finger 5 protein
Large fibroblast proteoglycan
CD59 glycoprotein precursor
Microtubule-associated protein IB
Importin a3 subunit
Gl/S-specific cyclin Dl (CCNDl)
Caveolin-l
ATP synthase coupling factor 6
Netrin-2
Macrophage inhibitory cytokine 1 (MICl)
Jun-B
Tissue-type plasminogen activator precursor
Mitogen-responsive phosphoprotein DOC2
Lysophospholipase homolog
Extracellular signal-regulated kinase 1 (ERKl)
IMP dehydrogenase 2 (IMPD2)
IFN-'Y transducer 1 (IFNGTl)
Eph-family protein
Hepatoma-derived growth factor (HDGF)
Integrin [33
VEGF receptor 1 (VEGFRl)
Shb proto-oncogene
Delta-like protein precursor (DLK)
Bone morphogenetic protein 4 (BMP4)
Endothelial PAI-l precursor
Butyrophilin precursor (BT)
Protein P84
Nuclear hormone receptor
Desmoplakin I and II
Glutathione-S-transferase homolog
Frizzled 5
Early growth response alpha (Egr-a)
Fos-related antigen (FRAl)
Thymus-expressed chemokine precursor
Ninjurin-l
C-fgr proto-oncogene (p55-FGR)
CD40 ligand (CD40-L)
Adenylosuccinate synthetase
VHL-binding protein 1 (VBPl)
Adenovirus EIA enhancer-binding protein
Active BCR-related protein
Apoptosis antigen ligand (APTL)
G1/S-specific cyclin E (CCNE)
Inducible protein
L-Lactate dehydrogenase H subunit (LDHB)
Interferon-a2 precursor (IFN-a)
BRCAl-associated ring domain protein
Platelet-derived growth factor A (PDGF -A)
G protein-coupled receptor GPR-NGA
EBI protein
Transforming protein rhoA H12 (RHO12)
Myxovirus (influenza) resistance 2
UMP synthase
CD5 precursor
High mobility group protein (HMG-I)
CD27 ligand (CD27LG)
IL-6R-a precursor
Early growth response protein 1 (Egr-l)
ing. Such biological variations have important implica- experimental data with the subject identities (indices
tions in the modeling of genetic network. For the mi- for cell batch) being randomly permuted (see subject-
croarray data present here, we tested whether this identity-permuted data sets in Simulated data sets,
converse reasoning holds by applying the C;-test to the above). If the better performance of a-test over
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ANOV A is indeed due to the existence of a large sub-
ject-subject variation, then the permutation should
eliminate the advantage of G-test over Al'irOV A, since
the subject-identity-permutation has no effect on
A
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~
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c
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(/J
0.2
0.0
0.0 0.2 0.4 0.6
1-Specificity
RGS3: P anaya = 0.18
0.8 1.0
B 4.0
I/) 3.5
Q)
~
"in 3.0
c
Q)
-2.5
ANav A. As can be seen by comparing the last two
columns of Table 1, this is exactly what happened. This
result provides experimental evidence that supports
the existence of relatively large individual variations
in the genome-wide regulation of gene expression in
response to a given stimulus.
Egr-l and related genes. The purpose of this paper is
to present a method for analyzing microarray data
rather than a detailed analysis of the effect of shear
stress on gene expression. We would like to use several
genes that have known time-dependent variations to
illustrate the utility of our new significance test. Two of
the genes most extensively studied for shear-modu-
lated gene expression in endothelial cells are early
growth response-1 (Egr-1) and platelet-derived growth
factor-A (PDGF -A). Both were picked up by the a-test
but missed by ANaVA (for Egr-1, Po = 0.01 and
PanDya = 0.07; for PDGF-A, Po = 0.01 and PanDya =
0.15). The shear-stimulated expression of Egr-1 was
transient, peaked at 1 h, and returned to basal level at
4 hand 24 h (Fig. SA). This is in excellent agreement
with the published time course (0 to 4-6 h) for shear-
stimulated Egr-1 expression in various types ofvascu-
lar endothelial cells obtained by Northern blot analy-
ses; all those studies found Egr-1 mRNA expression to
be transient, peaking at 0.5-1 h and returning to basal
level after 3-h shearing (7, 19, 27). The shear-stimu-
lated expression ofPDGF -A increased progressively up
to 4 h and returned to basal level at 24 h (Fig. 3B).
Again, this agrees very well with the published time
course (0 to 4 h) obtained by Northern blots (15, 19). It
is worth mentioning here that Egr-1 is a transcription
factor that binds to the proximal PDGF -A promoter as
a shear-stress-responsive element (19), which explains
the findings that the transient expression of Egr-1
mRNA precedes the PDGF -A gene expression.
It has been shown that Egr-1 also binds to the cyclin
D1 promoter and that this contributes to the enhance-
ment of cyclin D1 transcription by transforming
growth factor-a (30) and/or by angiotensin II (13) in an
extracellular signal-regulated kinase (ERK)-depen-
dent manner. It is well established that shear stress0.0
static 1 h 4h 2l~ h
Fig. 2. G-test has a higher sensitivity than ANDY A in detecting
treatment effects from micro array data in which the biological vari-
ability between subjects is large. A: G-test and ANDY A were applied
to simulated data that had prescribed the effects of treatments and
the subject-subject variation, with the latter being quantified by o-~
(see text). Dashed lines are for ANDY A, with the values of o-~ being
labeled. The solid line is for the G-test, which does not change with
o-~. The plot indicates that the G-test has a higher sensitivity at each
level of specificity than ANDY A when the subject-subject variation is
not small compared with the experimental error, i.e., when 0-" ~ 1,
and that this improvement in power increases as the subject-subject
variation increases. B: the data of microarray experiments indicate
that the subject-subject (i.e., between-cell batch) variation in the
expression levels of individual genes could be very large, as exem-
plified by the gene expression ofRGS3. Because of the large subject-
subject variation, ANDY A failed to detect an apparent consistency in
the expression pattern of RGS3, namely, the transient upregulation
by 1-h shear. C: the expression pattern ofRGS3 across all time points
was consistent, as indicated by closeness of the time courses after the
data were transformed via Eq. 3. This is reflected by a small P value
4h 24h returned by the G-test. RGS3, regulator of G protein signaling 3.
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Fig. 3. Erg-1 and related genes. Egr-1 is a transcription factor that binds to the promoter regions of many genes,
including PDGF-A and cyclin D1. The gene expressio:[lS of Egr-1 (A) and PDGF-A (B) were upregulated by shear
stress, with the peak expression of Egr-1 preceding that of PDGF-A. The time courses of Egr-1 and PDGF-A
expression shown in the microarray data agree ve~' well with the time courses of their mRNA expression in
endothelial cells established by Northern blotting analysis (14, 19,27). The gene expressions of cyclins D1 (C) and
E (D) were upregulated by shear stress with a time course suggesting a temporal lag following the transient
upregulation ofEgr-1, as in the established case ofPDIGF-A (see text). For each of these four genes, the a-test gave
a P ~ 0.01, while ANaVA produced a P > 0.05.
24 h
activates ERK (5, 16, 17, 20, 28). Therefore, it is rea-
sonable to postulate that the shear strl~ss-induced
transient expression of Egr-l may lead to ~Ln enhance-
ment in the gene expression of cyclin Dl at later times.
There are 11 cyclins presented in the Atlas 1.2 Cancer
array, of which two were significantly modulated by
shear according to the a-test: one is cyclin Dl (Pa <
0.01, Panova = 0.32), and the other is cyclin E (Pa <
0.01, Panova = 0.30). Both were upregulated by shear at
the later time points (Fig. 3, C and D), as E~xpected for
cyclin Dl. For a more liberal cutoff point P = 0.1, two
more cyclins were found to be significant. by a-test:
cyclins C (Pa = 0.06, Panova = 0.42) and D3 (Pa = 0.07,
Panova = 0.13); both displayed a time course similar to
those of cyclins Dl and E. It is interesting 1bo note that
5 of the 11 cyclins in the micro array we used are GliB
specific, that all four cyclins picked up by' a-test are
GliB specific, and that these four GliB-specific cyclins
showed similar temporal changes after shearing. In
Physiol Ge/1,omics .VOL 12 .
comparison, ANOV A did not pick up any of these cy-
clins (P > 0.1 for all 11 cyclins).
The other member of the Egr family present in the
microarray is Egr-a, which is highly expressed in the
early G1 phase of the cell cycle (3). In the present study,
the expression of Egr-a in endothelial cells was found to
be modulated significantly (Pa < 0.01, PanDya = 0.02) by
shear with a time course (Fig. 4A) very similar to that of
Egr-l. Egr-l and Egr-a are immediate early genes. An-
other immediate early gene found to be upregulated with
a peak at the early time point is Jun-B (Fig. 48, Pa <
0.01, PanDya < 0.01), with a time course similar to the
reported time course of C-Jun mRNA expression in re-
sponse to a steady flow (15). c-Jun was upregulated at the
early time point in the present study, but not statistically
significant (Pa = 0.2, PanDya = 0.5). To our knowledge,
there is no report in the literature about the effects of
shear on the time course of gene expression of Egr-a and
Jun-B, as well as the cyclins.
www.physiolgenomics.org
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A conventional one-way ANOV A in detecting treatment
effects from data produced by micro array experiments.
This improvement in sensitivity could be of critical
importance, as exemplified by the present study on the
temporal modulation of gene expression in endothelial
cells in response to shear stress. As shown in Table 1,
the number of genes showing significant differential
expression as determined by ANOV A is very close to
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Fig. 4. Microarray experiments showed that, in addition to the Egr-1
shown in Fig. SA, shear stress also transiently upregulated Egr-a (A)
and Jun-B (B) (Pa < 0.01, Panova = 0.02), two other iITlnlediate early
genes.
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Other example genes. Shown in Fig. 5 are three more
examples that illustrate the superior performance of
the G-test regardless of the temporal pattern of gene
expression. The time courses of the expreSSJlOn ofgenes
shown in Fig. 5 differ from those shown in Figs. 3 and
4. The gene expression level of caveolin-J. decreased
progressively (Pa < 0.01, Panova = 0.08) under shear.
Tyrosine-protein kinase receptor (Tie-2, jPa < 0.01,
Panova = 0.42) and matrix metalloproteinase 1 (MMP1,
Pa < 0.01, Panova < 0.01) were not responsive to short-
term shear but upregulated by 24-h shear. The differ-
ential expressions of these genes between static and
24-h shear have been confirmed by RT-PCR and/or
Northern blot analysis (6).
DISCUSSION
We have proposed a new model for differential gene
expression that explicitly specifies the effec:ts of exper-
imental treatments and biological variability and de-
veloped a corresponding multi-group test (G-test) for
the statistical significance of the treatment effects.
Using experimental and simulated data, we showed
that this new test is much more sensitiv'e than the
Physiol Genomics .VOL 12 .
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Fig. 5. The time courses of the expression of genes encoding caveo-
lin-l (A). Tie-2 (B), and matrix metalloproteinase 1 (MMPl) (C).
whose modulation by 24-h shear had been confirmed by RT-PCR
and/or Northern blotting (6).
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6. The proportion of genes tested positive that are truly positive
(PPV) increases as the sensitivity of the test in~~oaDos, when the
specificity of the test is fixed.
0.28
the number of false-positive genes one wou]ld expect for
a hypothetical situation in which none of the genes are
modulated by shear. For example, the number of genes
called significant by ANOV A is 18 at p.s 0.01 and 49 at
P .s 0.05. Assume that the 1,185 genes were not regu-
lated by shear, and that the measuremE~nts for the
1,185 genes were statistically independent (both are
not true). Then, on average, a statistical test would
classify 1,185 X P genes as regulated by shear because
P can be interpreted as the rate of false pol;itives (type
I error); 1,185 X 0.01 yields 12, and 1,185 ><: 0.05 yields
59; these numbers are almost the same as what are
called significant by ANOVA. Obviously, the perfor-
mance of ANOVA was not satisfactory. Jill contrast,
when the a-test was used, the number of genes with
positive test results is 61 at P .s 0.01 and 161 at P .s
0.05, which are more than three times the numbers of
false positives expected.
Naturally, one would ask whether the a-test may
have included too many genes that are not really sig-
nificant. To answer this question, we must first define
the meanings of positive and negative gene:s. When the
effects of experimental treatments are of interest, we
should regard a gene as a positive if some of the
treatments change the expression level of the gene, i.e.,
at least one of the <Y.ik n Eq. 1 is not zero. It is in this
sense that Fig. 2A compares the sensitivities of a-test
and ANOVA at each fixed level of specificiity, and the
results show that the a-test can markeclly improve
sensitivity without sacrificing specificity "'hen the bi-
ological variability is not small. We can address the
same question from another perspective by comparing
the positive predictive values (PPVs, i.e., the propor-
tion of genes tested positive that are true positives) of
the different tests. Unlike the sensitivity B.nd specific-
ity, the PPV of a test is a function of the p]~evalence of
positives (i.e., the proportion of the total number of
genes tested that are positive). Using Bayes' theorem,
it can be shown that (1)
sensitivity X prevalence ( )PPV= 6
.r
-~~ ~-3
sensitivity X prevalence
+ (1 -specificity) X (1 -prevalence)
Figure 6 plots PPV as a function of the sensitivity and
prevalence, with the specificity fixed at 0.£15. It is evi
dent that PPV increases with increasing sensitivity
Therefore, the set of genes selected by G-tl~st actuall)
had a smaller expected percentage of fal~e positives
than that by ANOV A.
Equation 6 points to a challenge one would face ill
identifying differentially expressed genel~ from mi-
croarray data. The power of the microarralY approach
lies in the fact that the number of genes assayed in a
single experiment can be very large, often 1m the order
of thousands or tens of thousands. When uEled to select
specific genes for further in-depth analysis, one would
like to have a large percentage of the selec1;ed genes to
be truly positive, i.e., having a high PPV. This could be
a challenge, because in many cases the prevalence of
positive genes on the micro arrays used with respect to
Physiol Genomics .VOL 12 .
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the particular experimental treatments is small, say,
less than 0.1. As shown in Fig. 6, the low prevalence
will lead to a small PPV, especially when the sensitiv-
ity is also low. To compare with the traditional gene-
by-gene approach, note that for an individual gene the
prevalence can be interpreted as the prior probability
that the gene is positive, and PPV as the posterior
probability that the gene is positive after it is tested to
be positive. In the gene-by-gene approach, e.g., North-
ern analysis, the small number of genes studied are
often selected exactly because they are expected to be
positives (differentially expressed) by the researcher
based on his/her prior knowledge; in other words, the
prevalence of positives is high, say, 0.5 or higher.
Therefore, as illustrated in Fig. 6, with the same sen-
sitivity and specificity, the PPV of a gene tested posi-
tive in a micro array study is likely to be lower than the
PPV of a gene tested positive in a gene-by-gene ap-
proach. For this reason, having a sensitive test for the
statistical significance of observed differential expres-
sion is a more critical issue for data from microarray
experiments than for data acquired by traditional
methods.
PPV is a measure of confidence one can place in a
positive call. Manduchi et al. (22) developed a novel
method to assign confidence to a differential gene ex-
pression assessed from micro array data. In a similar
way, one can show that
~~" Prob(called positive I negative) -~\
PPV~I-- 'I
Prob(called positive)
The probability "Prob(called positive I negative)" is the
preset cutoff point of P value, and "Prob(called posi-
tive)" can be estimated empirically from data as the
fraction of genes called positive by the test. When
applied to the results in Table 1, Eq. 7 yields a PPV ~
81 % for the 61 genes passed G-test at P = 0.01 and a
PPV ~ 34% for the 18 genes passed ANOV A at the
same cutoff point of P. This difference in PPV between, 
www.physiolgenomics.org
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the two tests increases dramatically as the cutoff point
of P is raised. At P = 0.02, PPV becomes 2:71% for
a-test and 1% for ANOV A; this very 10\\' confidence
level for the ANOV A test further illustratl9s the point
discussed at the beginning of this section. }.t the larger
cutoff points of P, Eq. 7 is no longer applicable to the
ANOV A results because it yields negative values. For
a-test, however, one obtains a PPV 2: 53% even at the
cutoff point of P = 0.1.
To compare with other previously descri1bed statisti-
cal tests designed for analysis of microarray data sets,
we have used PaGE (PaGE_4.0.pl) obtained from Com-
putational Biology and Informatics Laboratory at the
Center for Bioinformatics at the University ofPennsyl-
vania (http://www.pcbi.upenn.edu) to analyze the
present data set. The PaGE- 4.0 software b:v Manduchi
et al., which has been updated from their original
publication (22), can be used to identify differentially
expressed genes with a preset minimum level of confi-
dence. The application ofPaGE_4.0 to our data yielded
only two genes as differentially expressed at a mini-
mum confidence level of 81%, and seven genes at a
minimum confidence level of 53%. These genes do not
include Egr-1, PDGF -A, caveolin-1, and other genes
mentioned in RESULTS, whose expressions have been
known to be regulated by shear. Note that ,at the same
confidence levels (81% and 53%) a-test yielded, respec-
tively, 61 and 252 differentially expressed genes. The
better performance of the a-test over the, method of
Manduchi et al. (22) on the present data sets can be
explained by the same reasons given above for compar-
ing a-test and ANOVA, namely, the ability of a-test to
separate the subject-subject variation from other ran-
dom variations of experimental error, thUEI improving
the power of a statistical test. The comparison of a-test
with the method ofManduchiet al. again supports the
concept that the subject-subject variation in gene ex-
pression is not small and hence efforts sholud be made
to identify such variation in designing B. statistical
tests for gene expression data. Of course, such a test
will require certain features in experimentall design, as
described in ANALYTICAL METHODS.
The approach used in our microarray experiments
can be regarded as a "one-color" system. Allother plat-
form of micro array experiments is the "two-color" sys-
tem, in which the reverse-transcribed cDNA from two
samples labeled with two different fluorescent dyes are
mixed and then hybridized to a single microarray. This
allows the gene expressions in the two saJ:nples to be
measured simultaneously, and the ratio of the two
measurements from the same spot on thl9 same mi-
croarray is used as a data point. In experiIJrlents using
the two-color system, one of the two channels is often
used for a reference sample, and the ot;her for an
experiment sample. The a-test can be applied to ana-
lyze the data (i.e., the experiment/referE!nce ratios)
obtained from such experiments in a simila]: manner as
in the one-color system. For more complex experimen-
tal designs for the two-color system, modi.fications of
the statistical model would be needed.
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Although the focus of the present work is on testing
the significance of the treatment effects, the model
described by Eq. 1 also provides a basis for quantifying
and testing the biological variability in the regulation
of expressions of individual genes. Quantitative knowl-
edge about the biological variability at the level of
individual genes can be useful and might be necessary
in appropriately modeling the interaction of genes as a
network. We hypothesize that as a result of evolution,
rather than by design, a genetic network has a high
degree of redundancy which ensures its robustness and
that this redundancy provides flexibility in regulating
gene expression. As a result, there are great variabili-
ties in gene expression profiles between experiments
on different individuals or even between repeated ex-
periments on the same individual at different times.
Indeed, the finding that the a-test yielded many
more positive genes than ANOV A when applied to the
experimental data suggests that the biological vari-
ability in gene expressions is large compared with the
experimental random errors. This is consistent with
the previous findings that the sample-sample variation
of biological origin is greater than the spot-spot and
slide-slide variations of technical origins (2). The mi-
croarray technology is still evolving rapidly. Its future
advances will certainly reduce the extent of experimen-
tal errors. On the other hand, the biological variability
is simply a property of the system under study and will
remain large for any study in which conclusions are
meant to be applicable to a general population repre-
sented by the sampled subjects. Therefore, the ratio of
the variances due to the biological variability and ex-
perimental errors will be increased as the technology
improves and so will be the difference between the
sensitivities of the a-test and ANOV A, as indicated in
Fig. 2A.
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